|
Market Closed -
NYSE
05:00:00 17/11/2026 HKT
|
5-day change | 1st Jan Change | ||
| 3.030 USD | -0.66% |
|
+17.90% | +68.33% |
| 11-11 | Protalix BioTherapeutics, Inc. Reaffirms Earnings Guidance for the Full Year 2026 | CI |
| 11-10 | Protalix BioTherapeutics, Inc., Q3 2026 Earnings Call, Nov 10, 2026 |
Stock exchange
Quotes 5-day view: Protalix BioTherapeutics, Inc.
Delayed Quote NYSE| 09/11/2026 | 10/11/2026 | 11/11/2026 | 12/11/2026 | 13/11/2026 | |
|---|---|---|---|---|---|
| Last | US$2.570 | US$2.860 | US$3.130 | US$2.960 | US$3.050 |
| Volume | 792,061 | 3,039,599 | 3,092,811 | 2,436,756 | 1,588,435 |
| Change | +1.18% | +11.28% | +9.44% | -5.43% | +3.04% |
| Opening | US$2.530 | US$2.450 | US$2.860 | US$3.120 | US$2.940 |
| High | US$2.570 | US$2.965 | US$3.140 | US$3.130 | US$3.050 |
| Low | US$2.500 | US$2.450 | US$2.780 | US$2.920 | US$2.850 |
Performance
| 1 day | -0.66% | ||
| 1 week | +17.90% | ||
| Current month | +16.99% | ||
| 1 month | +15.65% | ||
| 3 months | +32.31% | ||
| 6 months | +58.64% | ||
| Current year | +68.33% | ||
| 1 year | +60.32% | ||
| 3 years | +117.99% | ||
| 5 years | +175.45% | ||
| 10 years | -41.73% |
Volumes
marketsDaily volume
1,288,313
Estimated daily volume
1,288,313
Avg. Volume 20 sessions
1,073,470
Daily volume ratio
1.2
Avg. Volume 20 sessions USD
3,252,614.1
Record volume 1
191,289,000
Record volume 2
19,414,390
Record volume 3
12,716,823
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (USD)
257,172,715
Net sales (USD)
52,744,000
Number of employees
226
Sales / Employee (USD)
233,381
Free-Float
96.29%
Free-Float capitalization (USD)
247,643,283
Average Daily Capital Traded
1.26%
Indicators
Moving average 5 days
2.914
Moving average 20 days
2.637
Moving average 50 days
2.682
Moving average 100 days
2.541
Price spread / (MMA5)
-3.83%
Price spread / (MMA20)
-12.97%
Price spread / (MMA50)
-11.50%
Price spread / (MMA100)
-16.14%
STIM
RSI 9 days
64.15
RSI 14 days
61.73
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.66% | +17.90% | +60.32% | +117.99% | 257M | ||
| -0.82% | +1.40% | +40.13% | +143.17% | 1,286B | ||
| -1.12% | +0.16% | +41.57% | +88.24% | 688B | ||
| -0.16% | +0.43% | +25.88% | +113.01% | 521B | ||
| +1.14% | +4.87% | +43.06% | +71.97% | 386B | ||
| -2.23% | -2.89% | +55.57% | +41.64% | 364B | ||
| +1.27% | +2.01% | +30.01% | +62.35% | 302B | ||
| +0.37% | +0.75% | +3.71% | +39.09% | 287B | ||
| -0.72% | -0.63% | +35.30% | +71.87% | 252B | ||
| -0.30% | -1.03% | +35.05% | +124.88% | 208B | ||
| Average | -0.05% | +3.88% | +37.06% | +87.42% | 429B | |
| Weighted average by Cap. | -0.12% | +3.26% | +36.53% | +98.00% |
Historical Quotes: Protalix BioTherapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
c2e8.QxT0mhYrgsJnOnuKdEuJpwZt0Xnl8GJp_U5WTEawLF0.CHGM6VUdw7gRfUPTPwfn9k0nnDK2k1pQtyIXLiz6YGp2RbjZb2_HjjgMIg
| Date | Price | Volume | Total |
|---|---|---|---|
| 05:00:00 | 3.030 | 39,213 | 1,170,450 |
| 04:59:57 | 3.030 | 100 | 1,131,237 |
| 04:59:57 | 3.030 | 100 | 1,131,137 |
| 04:59:57 | 3.030 | 200 | 1,131,037 |
| 04:59:56 | 3.030 | 100 | 1,130,837 |
| 04:59:56 | 3.030 | 100 | 1,130,737 |
| 04:59:56 | 3.030 | 100 | 1,130,637 |
| 04:59:56 | 3.030 | 200 | 1,130,537 |
| 04:59:56 | 3.020 | 200 | 1,130,337 |
Price Extremes
| 1 week | 2.45 | 3.14 | |
| 1 month | 2.45 | 3.14 | |
| Current year | 1.72 | 3.19 | |
| 1 year | 1.65 | 3.19 | |
| 3 years | 0.82 | 3.19 | |
| 5 years | 0.7 | 3.55 | |
| 10 years | 0.7 | 15.15 |
Monthly variations
Annual variations
| 2026 | +69.44% | ||
| 2025 | -4.26% | ||
| 2024 | +5.62% | ||
| 2023 | +29.93% | ||
| 2022 | +64.72% | ||
| 2021 | -77.09% | ||
| 2020 | +10.67% | ||
| 2019 | +5.47% | ||
| 2018 | -52.96% | ||
| 2017 | +48.58% | ||
| 2016 | -56.37% | ||
| 2015 | -44.57% | ||
| 2014 | -52.70% | ||
| 2013 | -25.05% | ||
| 2012 | +5.27% | ||
| 2011 | -50.60% | ||
| 2010 | +50.76% | ||
| 2009 | +259.78% | ||
| 2008 | -45.88% | ||
| 2007 | -87.48% |
- Stock Market
- Stocks
- PLX Stock
- Quotes Protalix BioTherapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
















